Skip to main content
. Author manuscript; available in PMC: 2013 Dec 15.
Published in final edited form as: Biol Psychiatry. 2012 Jun 19;72(12):1020–1025. doi: 10.1016/j.biopsych.2012.05.004

Table 1. Descriptive statistics.

Descriptive statistics of study participants, with median and interquartile ranges of sPECAM-1, sICAM-1, sVCAM-1, sP-Selectin, and sL-Selectin levels and the statistical significance between groups presented.

ASD (n=49) Control (n=31) P-Value
Male/Female 42 Male/7 Female 20 Male/11 Female
Age 2.9 years (2.7–3.4 years) 3.1 years (2.8–3.3 years)
sPECAM-1* 62.4 ng/ml (47.9–85.1 ng/ml) 81.5 ng/ml (72.4–99.2 ng/ml) 0.0129
sICAM-1 210 ng/ml (188.5–245.5 ng/ml) 208.5 ng/ml (174.5–237.4 ng/ml) 0.8978
sVCAM-1 670.2 ng/ml (595.9–756.5 ng/ml) 628.9 ng/ml (586.3–732.1 ng/ml) 0.2360
sP-Selectin* 40 ng/ml (31.4–53.5 ng/ml) 52.1 ng/ml (39.3–70.2 ng/ml) 0.0148
sL-Selectin 1328.00 ng/ml (1156–1465 ng/ml) 1300.00 ng/ml (1157–1543 ng/ml) 0.7222
HHS Vulnerability Disclosure